Comparison of the ⁹⁰Y-labelled glass microspheres liver radioembolisation dosimetry with the estimated dosimetry obtained from pre-treatment ^99mTc-MAA SPECT images reconstructed with and without attenuation correction

References

• Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, Wilhelm K, Biersack HJ, Ezziddin S. 2010. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med. 51(8):1206–1212.
   PubMed Web of Science ®Google Scholar
• American Cancer Society. 2016. Cancer facts & figures 2016. 1–9.
   Google Scholar
• Bhangoo MS, Karnani DR, Hein PN, Giap H, Knowles H, Issa C, Steuterman S, Pockros P, Frenette C. 2015. Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma. J Gastrointest Oncol. 6(5):469–478.
   PubMed Web of Science ®Google Scholar
• Botta F, Ferrari M, Chiesa C, Vitali S, Guerriero F, Nile MCD, Mira M, Lorenzon L, Pacilio M, Cremonesi M. 2018. Impact of missing attenuation and scatter corrections on99mTc-MAA SPECT 3D dosimetry for liver radioembolization using the patient relative calibration methodology: a retrospective investigation on clinical images. Med Phys. 45(4):1684–1698.
   PubMed Web of Science ®Google Scholar
• Brown S, Bailey DL, Willowson K, Baldock C. 2008. Investigation of the relationship between linear attenuation coefficients and CT Hounsfield units using radionuclides for SPECT. Appl Radiat Isotopes. 66(9):1206–1212.
   PubMed Web of Science ®Google Scholar
• Bult W, Vente MAD, Zonnenberg BA, Van Het Schip AD, Nijsen JFW. 2009. Microsphere radioembolization of liver malignancies: current developments. Q J Nucl Med Mol Imaging. 53(3):325–335.
   PubMed Web of Science ®Google Scholar
• Camacho JJC, Moncayo V, Kokabi N, Reavey HE, Galt JR, Yamada K, Kies DD, Williams RS, Kim HS, Schuster DM. 2015. (90)Y radioembolization: multimodality imaging pattern approach with angiographic correlation for optimized target therapy delivery. Radiographics. 35(5):1602–1618. http://www.ncbi.nlm.nih.gov/pubmed/26230755.
   PubMed Web of Science ®Google Scholar
• Demino L, Ferreira P, Oliveira FPMCosta DC. 2018. The importance of SPECT imaging attenuation correction during treatment planning for 90Y-labeled glass microspheres liver radioembolization. In: Tavares JMRS, Natal Jorge RM, editors. VipIMAGE 2017 ECCOMAS 2017 Lecture Notes in Computational Vision and Biomechanics. Cham: Springer International Publishing; 2018. p. 266–274.
   Google Scholar
• Ferreira P, Parafita R, Girão PS, Correia PL, Costa DC. 2017. Radioembolization with 90Y-labeled glass microspheres: analytical methods for patient-personalized voxel-based dosimetry. ECCOMAS 2017: VipIMAGE 2017; p. 185–191.
   Google Scholar
• Ferreira P, Parafita R, Girão PS, Correia PLCosta DC. Radioembolization with 90Y-labeled glass microspheres: Analytical methods for patient-personalized voxel-based dosimetry. In: Tavares JMRS, Natal Jorge RM, editors. VipIMAGE 2017 ECCOMAS 2017 Lecture Notes in Computational Vision and Biomechanics. Cham: Springer International Publishing; 2018. p. 185–191.
   Google Scholar
• Ferreira P, Radici L, Cutaia C, Valzano S, Lo Moro G, Pasquino M, Pellerito RE, Stasi M. 2016. Optimization of activity and absorbed doses calculation to target/tumor and normal liver volumes in patients submitted to Yttrium-90 radioembolization with glass microspheres. Physica MedMedica. 32:200.
   Google Scholar
• Garin E, Rolland Y, Laffont S, Edeline J. 2016. Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheres. Eur J Nucl Med Mol Imaging. 43(3):559–575.
   PubMed Web of Science ®Google Scholar
• Gnesin S, Canetti L, Adib S, Cherbuin N, Silva Monteiro M, Bize P, Denys A, Prior JO, Baechler S, Boubaker A. 2016a. Partition model-based 99mTc-MAA SPECT/CT predictive dosimetry compared with 90Y TOF PET/CT posttreatment dosimetry in radioembolization of hepatocellular carcinoma: a quantitative agreement comparison. J Nucl Med. 57(11):1672–1678.
   PubMed Web of Science ®Google Scholar
• Gnesin S, Leite Ferreira P, Malterre J, Laub P, Prior JO, Verdun FR. 2016b. Phantom validation of Tc-99m absolute quantification in a SPECT/CT commercial device. Comput Math Methods Med. 2016:1–6.
   Google Scholar
• Gulec, SA, Fong Y, Harpreet W, Wai-Tong LT, Warner RP, Kenneth P, Munci K, Michael H, Steven C. R, Smith R, et al. 2009. Practice guidelines integration of radiomicrosphere therapy into the contemporary management strategies for primary and metastatic liver cancer: oncology expert opinions and recommendations. J Interv Oncol. 2(1):46–58.
   Google Scholar
• Hamami ME, Td P, Müller S, Heusner T, Bockisch A, Hilgard P, Antoch G. 2009. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med. 50(5):688–692.
   PubMed Web of Science ®Google Scholar
• Haste P, Tann M, Persohn S, LaRoche T, Aaron V, Mauxion T, Chauhan N, Mr D, Ms J. 2017. Correlation of Technetium-99m macroaggregated albumin and Yttrium-90 glass microsphere biodistribution in hepatocellular carcinoma: a retrospective review of pretreatment single photon emission CT and posttreatment positron emission tomography/CT. J Vasc Interv Radiol. 28(5):722–730.e1.
   PubMed Web of Science ®Google Scholar
• KnesaurekKnešaurek K, Machac J, Muzinic M, DaCosta M, Zhang Z, Heiba S. 2010. Quantitative comparison of Yttrium-90 (90Y)-microspheres and Technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer. Technol Cancer Res Treat. 9(3):253–262.
   PubMed Web of Science ®Google Scholar
• NEMA. 2001. NU 2-2001: performance measurements of positron emission tomographs (PETs). NEMA Standards Publication NU 2-2001. 47.
   Google Scholar
• Oloomi S, Noori EH, Sr Z, Knoll P, Kalantari F, Hajizadeh SM. 2013. A new approach for scatter removal and attenuation compensation from SPECT/CT images. Iran J Basic Med Sci. 16(11):1181–1189.
   PubMed Web of Science ®Google Scholar
• Pedemonte S, Bousse A, Erlandsson K, Modat M, Arridge S, Hutton BF, Ourselin S. 2010. GPU accelerated rotation-based emission tomography reconstruction. IEEE Nuclear Science Symposuim & Medical Imaging Conference (T 5). Knoxville, Tennessee; p. 2657–2661.
   Google Scholar
• Selwyn RG. 2009. Radiomicrosphere therapy dosimetry. J Interv Oncol. 2(1):59–66.
   Google Scholar
• SmitsWu MLJ, Nijsen JF, van Den Bosch MA, Lam MG, Vente MA, Huijbregts JE, van Het Schip AD, Elschot M, Bult W, de Jong HW, et al. 2010. Holmium-166 radioembolization coronin-1C is a novel biomarker for the treatment of patients with liver metastases: design of the phase I HEPAR trialhepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation. J Exp Clin Cancer Res. 29(1):70.
   PubMedGoogle Scholar
• Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van Den Bosch MA, Nijsen JF, Lam MG. 2013. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. J Nucl Med. 54(8):1294–1301.
   PubMed Web of Science ®Google Scholar